Policy number: SRP 045
Policy name: Dysthyroid Eye Disease (Proptosis)
Status: Individual Funding Approval
Effective date: 1 April 2024
Next review date: 1 April 2029
Mid and south Essex ICB commissions surgery for proptosis on a restricted basis.
Funding will be provided to treat proptosis, arising from thyroid disease, as a result of enlargement of muscles in the socket and increased fatty tissue or abnormality of position of eyelid which causes extra exposure to the eye surface.
Surgery will only be offered for abnormality of the eyelid position after artificial tears have been tried for at least 6 months and failed.
Funding for patients not meeting the above criteria will only be granted in clinically exceptional circumstances.
Individual funding requests should only be made where the patient demonstrates clinical exceptionality.
Find out more information on applying for funding in exceptional clinical circumstances